159 related articles for article (PubMed ID: 30581498)
21. Genetic variability of DNA repair mechanisms influences chemotherapy outcome of gastric cancer.
Yu H; Wu X; Zhang Y; Jin Z; Li G; Zhao H
Int J Clin Exp Pathol; 2015; 8(4):4106-12. PubMed ID: 26097599
[TBL] [Abstract][Full Text] [Related]
22. Association Studies of ERCC2 rs13181 Polymorphism with Pancreatic Cancer Susceptibility.
Shao T; Kou J
Crit Rev Eukaryot Gene Expr; 2021; 31(2):17-23. PubMed ID: 34347976
[TBL] [Abstract][Full Text] [Related]
23. Association between ERCC2 Lys751Gln polymorphism and the risk of pancreatic cancer, especially among Asians: evidence from a meta-analysis.
Wu Y; Lu ZP; Zhang JJ; Liu DF; Shi GD; Zhang C; Qin ZQ; Zhang JZ; He Y; Wu PF; Miao Y; Jiang KR
Oncotarget; 2017 Jul; 8(30):50124-50132. PubMed ID: 28223548
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy: A meta-analysis in Chinese population.
Liu D; Liu X
Medicine (Baltimore); 2018 Dec; 97(49):e13358. PubMed ID: 30544402
[TBL] [Abstract][Full Text] [Related]
25. Influence of ERCC2 gene polymorphisms on the treatment outcome of osteosarcoma.
Liu ZF; Asila AL; Aikenmu K; Zhao J; Meng QC; Fang R
Genet Mol Res; 2015 Oct; 14(4):12967-72. PubMed ID: 26505449
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of GSTP1 Ile105Val polymorphism in clinical outcomes of chemotherapy in gastric and colorectal cancers: a systematic review and meta-analysis.
Shen X; Wang J; Yan X; Ren X; Wang F; Chen X; Xu Y
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1285-302. PubMed ID: 27154175
[TBL] [Abstract][Full Text] [Related]
27. Polymorphism of ERCC2 Asp312Asn with lung cancer risk: evidence from 20,101 subjects.
Tan X; Wang Y; Shi L; Xian L; Guo J; Liang G; Chen M
Genet Test Mol Biomarkers; 2014 Jan; 18(1):50-6. PubMed ID: 24083550
[TBL] [Abstract][Full Text] [Related]
28. Association of ERCC gene polymorphism with osteosarcoma risk.
Wang G; Li J; Xu X; Gupta RK; Gao X
Afr Health Sci; 2020 Dec; 20(4):1840-1848. PubMed ID: 34394247
[TBL] [Abstract][Full Text] [Related]
29. Association between common polymorphisms in
Li C; Yu X; Guo D; Liu G; Zhang K; Teng Q; Lin H
Onco Targets Ther; 2018; 11():3495-3504. PubMed ID: 29950854
[TBL] [Abstract][Full Text] [Related]
30. [Relationship between ERCC2 single nucleotide polymorphisms and male idiopathic infertility in Ningxia].
Liu CL; Jiao HY; Ma Q; Wu X; Jia ST; Jing WH; Yang QH
Zhonghua Nan Ke Xue; 2014 May; 20(5):419-22. PubMed ID: 24908732
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients.
Pérez-Ramírez C; Cañadas-Garre M; Alnatsha A; Villar E; Valdivia-Bautista J; Faus-Dáder MJ; Calleja-Hernández MÁ
Pharmacogenomics J; 2019 Apr; 19(2):164-177. PubMed ID: 29662106
[TBL] [Abstract][Full Text] [Related]
32. Association between ERCC2 polymorphisms and glioma risk: a meta-analysis.
Huang LM; Shi X; Yan DF; Zheng M; Deng YJ; Zeng WC; Liu C; Lin XD
Asian Pac J Cancer Prev; 2014; 15(11):4417-22. PubMed ID: 24969862
[TBL] [Abstract][Full Text] [Related]
33. Association between the ERCC2 rs13181 polymorphism and the risk of glioma: a meta-analysis.
Jia TL; Wu HJ; Wang HB; Ma WB; Xing B
Genet Mol Res; 2015 Oct; 14(4):12577-84. PubMed ID: 26505408
[TBL] [Abstract][Full Text] [Related]
34. Genetic variability of DNA repair mechanisms in chemotherapy treatment outcome of gastric cancer patients.
Zhong G; Li HK; Shan T; Zhang N
Genet Mol Res; 2015 Dec; 14(4):17228-34. PubMed ID: 26681216
[TBL] [Abstract][Full Text] [Related]
35. ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy.
Guberina M; Sak A; Pöttgen C; Tinhofer-Keilholz I; Budach V; Balermpas P; Von der Grün J; Rödel CM; Gkika E; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; De-Colle C; Welz S; Linge A; Lohaus F; Baretton G; Gauler T; Baumann M; Krause M; Schuler M; Bankfalvi A; Höing B; Lang S; Stuschke M
Pharmacogenomics J; 2021 Feb; 21(1):37-46. PubMed ID: 32546699
[TBL] [Abstract][Full Text] [Related]
36. Genetic Association between ERCC2, NBN, RAD51 Gene Variants and Osteosarcoma Risk: a Systematic Review and Meta-Analysis.
Mehdinejad M; Sobhan MR; Mazaheri M; Zare Shehneh M; Neamatzadeh H; Kalantar SM
Asian Pac J Cancer Prev; 2017 May; 18(5):1315-1321. PubMed ID: 28610420
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studies.
Qin Q; Zhang C; Yang X; Zhu H; Yang B; Cai J; Cheng H; Ma J; Lu J; Zhan L; Liu J; Liu Z; Xu L; Sun X
PLoS One; 2013; 8(11):e79864. PubMed ID: 24260311
[TBL] [Abstract][Full Text] [Related]
38. Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma.
Wang MJ; Zhu Y; Guo XJ; Tian ZZ
Genet Mol Res; 2015 Sep; 14(3):11652-7. PubMed ID: 26436406
[TBL] [Abstract][Full Text] [Related]
39. Association of ERCC2 Gene Polymorphisms with Susceptibility to Diffuse Large B-Cell Lymphoma.
Tong Y; Xiang Y; Li B; Bao S; Zhou Y; Yuan W; Ling Y; Hao D; Zhu H; Sun Z
Med Sci Monit; 2018 Oct; 24():7015-7022. PubMed ID: 30279407
[TBL] [Abstract][Full Text] [Related]
40. A pooled analysis of the ERCC2 Asp312Asn polymorphism and esophageal cancer susceptibility.
Wen F; Zhao Z; Liu C; Yin Q; Weng J; Wang Y; Ma Y
Tumour Biol; 2014 Apr; 35(4):2959-65. PubMed ID: 24234258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]